Ontology highlight
ABSTRACT:
SUBMITTER: Lin AY
PROVIDER: S-EPMC9724478 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature

Neuromuscular disorders : NMD 20191217 3
Inclusion body myositis (IBM) is a slowly progressive and heterogeneous disorder that is a challenge for measuring clinical trial efficacy. The current methods of measuring progression of the disease utilizes the Inclusion Body Myositis Functional Rating Scale, grip strength by dynamometer, and finger flexor strength. One of the hallmarks of the disease is selective deep finger flexor weakness. To date, no adequate data has been available to determine how well the Functional Rating Scale relates ...[more]